NEW YORK (GenomeWeb News) – Sigma-Aldrich and Enzo Biochem have settled a patent-infringement suit Enzo filed four years ago against Sigma and six other life science companies, Sigma-Aldrich said today.

 

While the terms of the settlement were not disclosed, Sigma said the settlement “will not have a material adverse effect on the consolidated financial condition, results of operations, or liquidity.”